Gene · 445
NIH grants1,983
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 1,983
Download this page as JSON| Grant | Title | ASS1 papers | Newest fiscal year |
|---|---|---|---|
| R35CA242427 | Reading mitochondrial apoptotic signaling to identify active cancer therapeutics | 1 | 2025 |
| R35CA264619 | Metabolic reprogramming of the tumor microenvironment and therapy resistance | 1 | 2025 |
| R35GM119770 | Multi-cellular and multi-scale systems modeling to understand the dynamics of the human immune system in interdisciplinary applications | 1 | 2025 |
| R35GM122480 | Proteomics and model organism humanization to decode human genetics | 1 | 2025 |
| R35GM124774 | A multi-scale systems biology framework for understanding and engineering the human gut microbiome | 1 | 2025 |
| R35GM130183 | Sulfide metabolism and signaling | 1 | 2025 |
| R35GM130361 | Regulation of mRNA Fate | 1 | 2025 |
| R35GM131781 | Discovering How Cu(II)/Zn(II) Uptake by the Prion Protein Controls Structure, Function and Neurotoxicity | 1 | 2025 |
| R35GM138113 | Illuminating Post-Transcriptional Regulation through Proteogenomic Integration | 1 | 2025 |
| R35GM142702 | Novel Statistical Methods for Multiscale Analysis of Single-cell Transcriptomes | 1 | 2025 |
| R35NS105078 | STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE | 1 | 2025 |
| R37AA020518 | Mechanisms regulating autophagy in alcohol-induced liver injury | 1 | 2025 |
| R37AG013925 | Effect of Aging on Preadipocyte Differentiation | 1 | 2025 |
| R37AI049653 | Differentiation and Function of Monocytes and Macrophages | 1 | 2025 |
| R37CA258346 | Targeting Nucleotide Metabolism to Overcome Therapy Resistance in Glioblastoma | 1 | 2025 |
| R50CA211199 | Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level | 1 | 2025 |
| R50CA211399 | Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer | 1 | 2025 |
| R50CA211437 | Revealing cancer metabolism via mass spectrometry and isotope tracers | 1 | 2025 |
| R50CA243890 | The Development and Optimization of Long-Read Sequencing Applications to Cancer Genomics in a Core Setting | 1 | 2025 |
| T15LM007093 | NLM Research Training Program in Biomedical Informatics and Data Science for Predoctoral and Postdoctoral Fellows | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/grants?page=14